BRIMONIDINE TARTRATE OPHTHALMIC SOLUTION
Google image searchProduct monograph
Active ingredient
brimonidine tartrate, 0.2 %/W/V
DIN: 02515377
Dosage form(s): SOLUTION
Route(s) of administration: OPHTHALMIC
Schedule: Prescription
Company: HIKMA CANADA LIMITED
Date: 31-MAY-2023
ATC:
- S01 — OPHTHALMOLOGICALS (ATC, ATC/DDD, )
- S01E — ANTIGLAUCOMA PREPARATIONS AND MIOTICS (ATC, ATC/DDD)
- S01EA — Sympathomimetics in glaucoma therapy (ATC, ATC/DDD)
- S01EA05 — BRIMONIDINE (ATC/DDD)
Reference brand drug: Alphagan
